IAIM
NVRO

International Assets Investment Management’s NEVRO CORP. NVRO Stock Holding History

International Assets Investment Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$34 – 2706
2024
Q2 		$34 Buy
+4
New +$43 ﹤0.01% 2255

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

International Assets Investment Management's NVRO Position: Q3 2024 in Review

International Assets Investment Management sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 4 shares — an estimated $34 sold.

International Assets Investment Management first reported a position in NVRO in Q2 2024 and held it in 1 quarter. The position peaked at $34 in Q2 2024. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • International Assets Investment Management reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • International Assets Investment Management sold 4 NEVRO CORP. shares in Q3 2024, an estimated $34.
  • International Assets Investment Management first reported a position in NEVRO CORP. in Q2 2024 and held it in 1 quarter.
  • International Assets Investment Management's NEVRO CORP. position peaked at $34 in Q2 2024.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on International Assets Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.